fwiw: OT: FDA Alert - Update of Healthcare Professional Information: Tysabri (natalizumab)

[Guest guest]

fwiw:

http://www.drugs.com/fda/tysabri-natalizumab-update-healthcare-professional-12950.html

Sent to you from Drugs.com

FDA MedWatch Alert

Sent to subscribers of: Tysabri

Update of Healthcare Professional Information: Tysabri (natalizumab)

April 22, 2011

Audience: Neurological healthcare professionals, patients.

[uPDATED Posted 04/22/2011] FDA has updated the Tysabri (natalizumab) Prescribing Information to give new information about the size of the risk of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection, associated with use of Tysabri for the treatment of multiple sclerosis (MS) and Crohn's disease.

Read more...

Get these updates via twitter

Drugs.com. All rights reserved.